Natali_Mis/iStock via Getty Images I worried about Becton, Dickinson and Company’s (NYSE:BDX) weak China growth as discussed in my introductory article. On February 1, BD released their Q1 FY24. China declined 5.3% year-over-year, and now the market only represents 6.4% of group revenue. Other major challenges, including the Alaris pump and Covid comparisons, are starting to get normalized, and the stock price is undervalued; therefore, I upgrade the rating from ‘Hold to ‘Buy’ with a fair value of $250 ...

The stock market bulls are charging right now. The Federal Reserve appears set to lower interest rates this year, which could stoke equity markets. Meanwhile, the emergence of AI has powered tech stocks higher.However, some analysts are worried that this rally could come crashing down. Given high valuation multiples on many leading momentum stocks right now, this is a tricky time to put capital to work.The good news, though, is that there are still plenty of good investment opportunities for long-term inves ...

FRANKLIN LAKES, N.J., Feb. 27, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Dave Hickey has informed the company of his intent to retire from BD, effective July 1. Hickey is currently executive vice president and president of the Life Sciences segment for BD, a position he has held since January 2021. Prior to his current role, Hickey was president of Integrated Diagnostic Solutions from 2019 to 2021, and president of ...

Becton, Dickinson and Company (BDX) , popularly known as BD and Camtech Health, recently announced their strategic collaboration to uplift cervical cancer screening for women in Singapore by providing them the first-ever option to self-collect a sample amidst the privacy of their own home.The partnership is intended to raise the percentage of cervical cancer screening in Singapore, where the present screening rate is less than half of eligible women.Price PerformanceFor the past six months, BDX’s shares hav ...

First-Ever Program in the Country to Offer At-Home Self-Collection of Samples for HPV TestingSINGAPORE, Feb. 21, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic partnership with Camtech Health, a digital health company focused on at-home health testing, to advance cervical cancer screening by offering the first-ever option for women in Singapore to self-collect a sample in the privacy of their own home. BD annou ...

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Becton Dickinson (BDX) or West Pharmaceutical Services (WST) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our ...

FRANKLIN LAKES, N.J., Feb. 12, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next installment of its BD Innovates series — which will highlight BD solutions that help clinicians treat Peripheral Vascular Disease — on Monday, February 26, 2024, at 3:00 PM Eastern Time.The BD Innovates series spotlights BD's innovation, products and pipeline in support of its BD 2025 Strategy, with this installment hig ...

Becton, Dickinson and Company (BDX) , popularly known as BD, is well-poised for growth in the coming quarters, courtesy of its series of product launches over the past few months. The optimism led by a solid first-quarter fiscal 2024 performance and a few regulatory approvals are expected to contribute further. However, macroeconomic concerns and forex volatility persist.Over the past year, this Zacks Rank #3 (Hold) stock has lost 7.2% against the 7.3% rise of the industry and 19.2% growth of the S&P 500.Th ...

| --- | --- | --- | --- | --- | |--------------------------|-------|-----------------------|-----------|-------------------| | | | | | | | | | | | | | | | | | | | Q1 FY24 February 1, 2024 | | Earnings Presentation | | | | | | | Advancing | the | | | | | | world of healthTM | Caution Concerning Forward-Looking Statements This presentation and accompanying audio webcast contain certain estimates and other forward-looking statements (as defined under federal securities laws) regarding BD's future prospects and ...

Becton, Dickinson and Company (NYSE:BDX) Q1 2024 Earnings Conference Call February 1, 2024 8:00 AM ET Company Participants Greg Rodetis - SVP, Treasurer & Head of IR Tom Polen - Chairman, President & CEO Christopher DelOrefice - EVP & CFO Michael Garrison - EVP & President, Medical Segment Dave Hickey - EVP & President, Life Sciences segment Conference Call Participants Rick Wise - Stifel Travis Steed - Bank of America Vijay Kumar - Evercore ISI Lawrence Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Patr ...